Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Scientific Reports|August 20, 2017
Global methylation correlates with clinical status in multiple sclerosis patients in the first year of IFNbeta treatmentMaría Jesús Pinto-Medel, Begoña Oliver-Martos, Patricia Urbaneja-Romero, et al.
Scientific Reports|November 30, 2017
Cross-reactivity of antibodies against interferon beta in multiple sclerosis patients and interference of the JAK-STAT signaling pathwayIsaac Hurtado-Guerrero, Maria Jesus Pinto-Medel, Patricia Urbaneja, et al.
Bioanalysis|November 17, 2015
Development and validation of an ELISA for quantification of soluble IFN-β receptor: assessment in multiple sclerosisTeresa Órpez-Zafra, Jose Pavía, Maria J Pinto-Medel, et al.
The International Journal of Neuroscience|May 18, 2012
Chronic immobilization in the malpar1 knockout mice increases oxidative stress in the hippocampusMaría García-Fernández, Estela Castilla-Ortega, Carmen Pedraza, et al.
Journal of Clinical Medicine|July 30, 2020
Skin Phototype Could Be a Risk Factor for Multiple SclerosisPatricia Urbaneja, Isaac Hurtado-Guerrero, Miguel Ángel Hernández, et al.
Frontiers in Immunology|September 7, 2023
Natalizumab-immunogenicity evaluation in patients with infusion related events or disease exacerbationsNicolás Lundahl Ciano-Petersen, Pablo Aliaga-Gaspar, Isaac Hurtado-Guerrero, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 11, 2016
Decreased soluble IFN-β receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarkerTeresa Órpez-Zafra, Jose Pavía, Isaac Hurtado-Guerrero, et al.
Pageof 2